Role of Cytoreductive Nephrectomy Unclear for Dedifferentiated Kidney Cancer
AUSTIN, Texas — Cytoreductive nephrectomy improved overall survival (OS) by more than a year for patients with metastatic renal cell carcinoma (mRCC) with sarcomatoid or rhabdoid (S/R) dedifferentiation treated with immunotherapy in an observational study, but the difference did not achieve statistical significance. Median OS was 30 months with surgery versus 17 months without, representing […]